University of South Florida

Digital Commons @ University of South Florida
Neurosurgery and Brain Repair Faculty
Publications

Neurosurgery and Brain Repair

2017

Chronic Inflammation and Apoptosis Propagate in Ischemic
Cerebellum and Heart of Non-human Primates
Sandra A. Acosta
University of South Florida

Sherwin Mashkouri
University of South Florida

Diana Nwokoye
University of South Florida

Jea Y. Lee
University of South Florida, jeayoung@usf.edu

Cesar V. Borlongan
University of South Florida, cborlong@usf.edu

Follow this and additional works at: https://digitalcommons.usf.edu/nbr_facpub
Part of the Neurosurgery Commons

Scholar Commons Citation
Acosta, Sandra A.; Mashkouri, Sherwin; Nwokoye, Diana; Lee, Jea Y.; and Borlongan, Cesar V., "Chronic
Inflammation and Apoptosis Propagate in Ischemic Cerebellum and Heart of Non-human Primates"
(2017). Neurosurgery and Brain Repair Faculty Publications. 22.
https://digitalcommons.usf.edu/nbr_facpub/22

This Article is brought to you for free and open access by the Neurosurgery and Brain Repair at Digital Commons @
University of South Florida. It has been accepted for inclusion in Neurosurgery and Brain Repair Faculty
Publications by an authorized administrator of Digital Commons @ University of South Florida. For more
information, please contact scholarcommons@usf.edu.

www.impactjournals.com/oncotarget/

Oncotarget, 2017, Vol. 8, (No. 61), pp: 102820-102834
Research Paper: Pathology

Chronic inflammation and apoptosis propagate in ischemic
cerebellum and heart of non-human primates
Sandra A. Acosta1,*, Sherwin Mashkouri1,*, Diana Nwokoye1, Jea Y. Lee1 and Cesar
V. Borlongan1
1

Department of Neurosurgery and Brain Repair, University of South Florida Morsani College of Medicine, Tampa, Florida, USA

*

These authors have contributed equally to this work

Correspondence to: Cesar V. Borlongan, email: cborlong@health.usf.edu
Keywords: secondary injury, neurodegeneration, cell death, Purkinje cells, Pathology Section
Received: March 14, 2017

Accepted: May 17, 2017

Published: June 01, 2017

Copyright: Acosta et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY
3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ABSTRACT
The major pathological consequences of cerebral ischemia are characterized by
neurological deficits commonly ascribed to the infarcted tissue and its surrounding
region, however, brain areas, as well as peripheral organs, distal from the original
injury may manifest as subtle disease sequelae that can increase the risks of comorbidities complicating the disease symptoms. To evaluate the vulnerability of the
cerebellum and the heart to secondary injuries in the late stage of transient global
ischemia (TGI) model in non-human primates (NHP), brain and heart tissues were
collected at six months post-TGI. Unbiased stereological analyses of immunostained
tissues showed significant Purkinje cells loss in lobule III and lobule IX of the
TGI cerebellum relative to sham cerebellum, with corresponding upregulation of
inflammatory and apoptotic cells. Similarly, TGI hearts revealed significant activation
of inflammatory and apoptotic cells relative to sham hearts. Aberrant inflammation
and apoptosis in the cerebellum and the heart of chronic TGI-exposed NHPs suggest
distal secondary injuries manifesting both centrally and peripherally. These results
advance our understanding on the sustained propagation of chronic secondary injuries
after TGI, highlighting the need to develop therapeutic interventions targeting the
brain, as well as the heart, in order to abrogate cerebral ischemia and its related comorbidities.

INTRODUCTION

death signals in cardiac tissue are upregulated following
cerebral ischemia in both in vitro experiments and in vivo
rodent models [7, 10]. These observations potentially
explain the notable percentage of cardiac-related deaths
in humans within 3 months of ischemic cerebral injury
[7, 11, 12]. Recently, we provided a proof-of-concept
that cerebral ischemia produces secondary cell damage
in distal organs, especially the heart [7], using the
ischemic stroke model in rodents. The mechanism of
action was explored by exposing primary rat neuronal
cells to oxygen-glucose deprivation (OGD) that caused a
significant decrease in cellular vitality and mitochondrial
activity in rat cardiomyocytes [7]. Our in vivo results
further demonstrated that ischemic stroke models induced
rat cardiomyocyte cell death [7]. Altogether, these results
revealed that all cell death markers were detectable in both
the brain and the heart after ischemic stroke, advancing the

Global ischemic injury caused by circulatory arrest
has long been associated with physical changes in the
human brain [1]. To date, these brain tissue modifications
that follow global ischemia have been studied using both
nonsurgical [2, 3] and surgical models [4]. Recently,
minimally invasive surgical procedures have allowed
researchers to safely and efficiently produce transient
global ischemic injury in animal models [5]. Multiple
studies have demonstrated that global ischemia is directly
associated with localized neuronal damage in vulnerable
brain areas such as the hippocampus and neocortex [5, 6].
A pathologic link may exist between neuronal
death caused by cerebral ischemia and subsequent
cardiac myocyte vulnerability [7-9]. Indeed, cellular
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concept of a pathological link between the cerebrovascular
and cardiovascular diseases.
Cerebrovascular and cardiovascular disease share
several predisposing factors including hypertension,
diabetes, hyperlipidemia, and family history of heart
disease [13-21]. Research has shown a higher likelihood of
cardiac cell death following an ischemic cerebrovascular
episode, which is thought to be due to elevated levels
of plasma catecholamines and cardiac enzymes, such
as troponin and creatine phosphokinase [11, 12]. In
addition, extreme ischemic events have been linked to
increased levels of brain natriuretic peptide (BNP) [1321]. The increased presence of this biomarker following
ischemia suggests a crosstalk between the brain and
heart after cerebral ischemia [19-22]. Furthermore,
inflammation following ischemic stroke may serve as
another pathological pathway connecting the brain and
the heart. In particular, C-reactive protein (CRP) which is
elevated during periods of inflammation within the body,
presents as the specific factor found to be associated with
the risk of new cardiovascular events in stroke patients
[12], implicating inflammation as a key factor in the
cascade of cell death events which may originate from the
stroke brain and migrating to the heart. Although the exact
mechanism linking cerebral ischemia with cardiac damage
is not fully understood, further investigations are required
to understand the overlapping molecular, cellular, and
anatomical alterations seen in the heart following cerebral
ischemia.
A clinically relevant model, such as the non-human
primate (NHP) model of ischemia, may allow a better
understanding of the cerebrovascular and cardiovascular
event. Here, we demonstrated that brain and heart tissues
harvested from NHPs that suffered transient global
ischemia (TGI) months earlier displayed degenerative and
inflammatory markers, further advancing the concept that
distal secondary injuries and the development of chronic
neuropathological manifestations propagate to both the
brain and heart. In the clinic, such a brain-heart cell death
crosstalk may indicate an integration of cerebrovascular
and cardiovascular diagnostic assessments into standard
clinical treatment and management of both diseases.

lobule III and lobule IX compared to the same areas in
the cerebellum of the sham NHPs (Student t-test, p’s <
0.05), indicating TGI resulted in secondary damage to
the cerebellum. In contrast, the expression of calbindin+
Purkinje cells in the other lobules of TGI NHP did not
significantly differ compared to the respective lobules in
the sham NHPs (Student t-test, p’s > 0.05) (Figure 1A-1M
Figure 2), indicating that that calbindin cell loss was more
pronounced in lobule III and lobule IX of the cerebellum
at six months post-TGI.

Increased TUNEL+ expression in the cerebellum
after TGI positively correlates with Purkinje cell
loss
TUNEL expression in the cerebellum was analyzed
using immunofluorescence to reveal the necrotic/apoptotic
effect of delayed TGI NHPs. The mean TUNEL expression
was markedly increased in all cerebellar lobules of the
TGI NHPs compared to all cerebellar lobules from
the sham NHPs (Student t-test, p < 0.05), suggesting a
rampant cell death throughout the cerebellar region at
this chronic phase post-ischemia. Pearson’s correlation
analysis between TUNEL+ staining intensity of each
individual cerebellar lobule and the percent of Purkinje
cell loss of each individual cerebellar lobule revealed a
positive significant correlation (R2 = 72.18; Pearson’s r =
0.8496) ( Figure 3A, 3B, 3C).

Increased gliosis and pathological
expression in the cerebellum after TGI

GFAP and TNF-α expression in the cerebellum was
analyzed using immunofluorescence techniques to reveal
chronic secondary neuroinflammation in the cerebellum
of the delayed TGI model in NHPs. The mean staining
intensity of GFAP and TNF-α of the cerebellum revealed
a significant pathological increase in the granule cell layer
of the cerebellum of the delayed TGI NHPs relative to
the cerebellum of the sham NHPs (Student t-test, p’s <
0.05) (Figure 3D, 3E, 3F). These results indicate persistent
neuroinflammation in this chronic TGI NHP model.

RESULTS

Increased monocyte HLA-DR+ and macrophage
CD68+ cells expression in the cerebellum after
TGI

TGI decreases the volume of calbindin+ Purkinje
cells in cerebellar lobules

HLA-DR and CD68 expression in the cerebellum,
specifically in the granular layer, was analyzed using
immunofluorescence techniques to reveal markers of
immune response and macrophages, respectively. The
mean staining intensity in the cerebellum revealed a
significant increased expression of HLA-DR and CD68+
macrophages in the granular layer of the delayed TGI

Calbindin+ expression in every single lobule from
the cerebellum was analyzed using immunohistochemistry
and Cavalieri estimator techniques to reveal the secondary
detrimental effects of delayed TGI on Purkinje cells.
There were significant reductions in calbindin+ Purkinje
cells in the cerebellum of the TGI NHPs, specifically in
www.impactjournals.com/oncotarget
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Figure 1: Increased Purkinje cell loss in cerebellar lobules after TGI. A. Representative photomicrographs correspond to the

outline of individual lobules of the cerebellum that were used for stereological analysis. B.-L. Quantitative analyses of the total number
of Purkinje cells in each individual lobule of the cerebellum revealed significant cell loss in lobules III E. and IX (K) after TGI when
compared to the respective lobules in the sham NHP (*p’s > 0.05). M. Representative photomicrographs of lobule III and lobule IX of TGI
and sham animals taken from lateral sections of the cerebellum. Arrows denote positive staining for calbindin+ cells, which is characteristic
of Purkinje cells residing in the cerebellum of TGI and sham animals. Scale bar: 50 µm. Student t-test, p’s > 0.05. Calbindin+ cells are
expressed as estimated volume of positive cells. PCL: Purkinje cell layer; GCL: Granular cells layer; ML: Molecular layer. Data are
expressed as mean ± SEM.
www.impactjournals.com/oncotarget
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NHPs relative to the granular layer of the sham NHPs
(Student t-test, p’s < 0.0001) (Figure 4A, 4B, 4C). These
results indicate an upregulation of the immune response in
the cerebellum at several months after TGI.

staining intensity in the heart revealed a significant
increase expression of HLA-DR and TNF-α in the left
ventricle of the delayed TGI NHPs relative to the left
ventricle of the sham NHPs (Student t-test, p’s < 0.0001)
(Figure 5D, 5E, 5F).

Increased monocyte HLA-DR+ and caspase 3+
expression in the heart after TGI

Increased CD68+ cells expression in the heart
after TGI

HLA-DR and caspase 3 expression in the heart,
specifically in the left ventricle was analyzed using
immunofluorescence techniques to reveal markers of
immune response and upstream regulator of apoptosis,
respectively. The mean staining intensity in the heart
revealed a significant increased expression of HLA-DR
and caspase 3 staining in the left ventricle of the delayed
TGI NHPs relative to the left ventricle of the sham NHPs
(Student t-test, p’s < 0.0001) (Figure 5A, 5B, 5C). These
results indicate a robust cardiac immune response and
apoptotic response was detectable even at several months
after TGI.

Similarly, CD68 expression in the heart samples was
analyzed using immunofluorescence techniques to reveal
the presence of macrophages. The mean staining intensity
in the heart revealed a significant increased expression of
CD68+ macrophages in the delayed TGI NHPs relative to
sham NHPs (Student t-test, p’s < 0.0001) (Figure 5G, 5H).
These results implicate a robust cardiac immune response
detectable even at several months after TGI.

DISCUSSION
In the present study, we investigated the
degenerative consequences of global cerebral ischemia
model in distal areas including the cerebellum and the
heart. Six months after TGI, detailed analyses of the NHP
cerebellum indicated a massive reduction in Purkinje cell
survival within cerebellar lobule III and lobule IX. Further
analysis revealed widespread and significant apoptotic
and inflammatory responses in the TGI NHP cerebellum.
Similarly, we detected a significant increase in specific
pro-cell death immune, apoptotic, and inflammatory

Increased monocyte HLA-DR+ and TNF-α+
expression in the heart after TGI
To capture an interaction between immune response
and inflammation in the heart as potential pathway of the
observed apoptotic cardiac cell death, we next examined
immunofluorescent expression of HLA-DR and TNF-α
in the heart, specifically in the left ventricle. The mean

Figure 2: Total number of Purkinje cells in each individual lobule of the cerebellum after TGI. A. Summary bar graph of

quantitative analyses of total number of Purkinje cells in each individual lobule of the cerebellum. Analysis revealed significant cell loss in
lobules III and IX after TGI when compared to the respective lobules in the sham NHPs (*p’s > 0.05). Student t-test, p’s > 0.05. Calbindin+
cells are expressed as estimated volume of positive cells. B. Schematic representation of the superior view of the cerebellum displaying
the vermis, hemispheres and lobules. Pink highlighted areas represent the lobules with Purkinje cell loss post-TGI. Data are expressed as
mean ± SEM.
www.impactjournals.com/oncotarget
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Figure 3: Increased apoptotic cells, astrogliosis, and TNF-α in the cerebellum after TGI. A. Quantitative analysis of TUNEL
expression in the granule layer of the cerebellum revealed a significant upregulation of TUNEL intensity after TGI relative to sham (*p <
0.05). B. Graph illustrates the correlation between TUNEL staining intensity and percent (%) of Purkinje cell loss in each lobule. There
was a significant positive correlation between TUNEL staining intensity and percent of Purkinje cell loss in vulnerable lobules (R2 = 72.18;
Pearson’s r = 0.8496). C. Representative confocal photomicrographs of positive expression of TUNEL (green) and Hoechst (blue) in the
granule layer of the cerebellum of sham (top panel) and TGI (bottom panel), showing increased expression of TUNEL in the cerebellum of
TGI relative to sham. Scale bar: 50 µm. Student t-test, p < 0.05. Data are expressed as mean ± SEM. D., E. Fluorescent intensity analysis
of GFAP+ cells and TNF-α in the cerebellum revealed significant upregulation of GFAP+ cells in the cerebellum of the TGI NHP compared
to the sham NHP (p’s < 0.05). F. Representative photomicrographs correspond to lateral cerebellar sections showing the molecular and
granule layers of the cerebellum stained with GFAP (astrocyte marker) and TNF-α (pro-inflammatory cytokine marker) after TGI. Arrows
indicate positive staining for GFAP+ cells and TNF-α+ expression. Scale bar = 50 µm. Student t-test, p’s < 0.05. PCL: Purkinje cell layer;
GCL: Granular cells layer; ML: Molecular layer. Data are expressed as mean ± SEM.

markers in the heart in chronic phase following TGI.
Altogether, these results suggest that the originally
reported hippocampal cell death as the primary ischemic
injury is not the only pathological consequence following
TGI, but there are also secondary injury events in distal
regions, such as the cerebellum and the heart that may
persist over a prolonged period post-ischemia.
In the cerebellum, the expression of calbindin, which
is specific marker for Purkinje cells, displayed a localized
decrease in lobule III and IX in the cerebellum. TUNEL
analysis confirmed the widespread apoptotic signal
within the cerebellum relative to sham cerebellum. The
brain may represent the most sensitive organ to hypoxia
or ischemic injuries [23]. Several distinct characteristics
of the brain may contribute to its increased susceptibility
to low oxygen levels, including its high oxygen and
glucose consumption coupled with low storage levels
of glucose/glycogen and high metabolic functions [24,
25]. Interestingly, neural germinal zones like SVZ,
the hippocampus, and even parts of the cerebellum at
postnatal periods [26-31], are fenestrated with massive
supply of vasculature and oxygen-supporting cells, such as
pericytes, which may contribute to the stemness fate and
functional phenotype of neural progenitor cells (NPCs).
Delivery of oxygen to neurogenic niches is of critical
importance for their proliferative, and inmunomodulatory
function, in fact, HIF-1a is upregulated when low
oxygen levels are detected, thus activating angiogenic
and vasculogenic pathways to increase blood flow [32].
However, this endogenous response is not sufficient to
arrest the cell death cascade. Accordingly, despite such
complex vascular fenestrations of the neurogeneic niches,
these unique oxygen-dependent features may indicate
a higher demand for energy metabolism, increasing the
vulnerability of these regions during ischemic conditions.
In parallel, cultured endothelial cells secrete factors to
stimulate proliferation of neural precursor and induced
their differentiation to a neuronal fate [33], suggesting
that targeting these neurogenic niches with exogenous
stem cells may boost the endogenous neurogenesis thereby
abrogating pathological conditions, such as ischemic
insults. Previous studies have demonstrated the susceptible
nature of cerebellar Purkinje cells following ischemic
insult, which is partly due to their high metabolic activity
www.impactjournals.com/oncotarget
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[34-37]. Downregulated levels of neuronal metabolism
by blood flow in cerebellar hemisphere are frequently
reported on positron-emission tomography (PET) and
single-photon emission CT (SPECT) in stroke patients
[38]. In unilateral stroke, this phenomenon is referred
to as crossed cerebellar diaschisis or CCD. After stroke,
there is a marked depression of metabolic function and
activity manifested as reduced blood flow in the cerebellar
hemisphere contralateral to a supratentorial infarct which
it is likely to interrupt the corticopontocerebellar fibers and
to cause a downregulation of synaptic cerebellar Purkinje
cell function and perfusion [38, 39]. Interestingly, long
term chronic CCD instigate cerebellar volume loss in
patients after supratentorial ischemic infarct [39]. Such
phenomenon of diaschisis in patients has been documented
in stroke animals [40, 41]. A topographic study has
revealed anatomical and functional hallmarks of specific
cerebellar lobules [42]. Lobule III, a key component in
the anterior lobe of the cerebellum, is predominantly
responsible for leg and foot sensorimotor function [42-44].
Meanwhile, lobule IX is located in the posterior cerebellar
lobe and functions in the visual guidance of movement,
thereby utilizing visual information to direct movements
and adjust reflexes appropriately [42-46]. Lesions
affecting the anterior lobe vermal lobules I-III as well as
posterior lobules VIII and IX can result in balance and gait
instability [42]. Clinically, balance and gait disability are a
common secondary condition following cerebral ischemia
[44-53], and could potentially be reflected in the present
observation of distal neurodegeneration in the cerebellum
seen in our TGI NHPs.
Furthermore, exacerbation of GFAP or astrogliosis
along with secretion of pro-inflammatory cytokines,
including TNF-α, are known to be highly expressed in
the central nervous system during neurologic diseases
associated with inflammation [54-57]. GFAP and TNF-α
immunofluorescent staining showed increased expression
in the area of the granule layer of the cerebellum, which
further supports the ongoing secondary damage and
inflammatory events during delayed ischemia. In line with
our findings, previous studies have revealed that hypoxicischemic injured rats often present a significant increase
in GFAP-positive cell density in posterior region of the
brain and further distally to the cerebellar cortex [57].
Oncotarget

Clinical studies have documented similar exacerbation
of reactive astrocytosis in the brains of human infants
following perinatal hypoxic-ischemic insult [58, 59].
The significant increase in TNF-α in the cerebellum is
consistent with previous studies detailing a strong and
persistent inflammatory response following ischemic
insult [60-63].
Reactive astrocytosis and secretion of proinflammatory cytokines further reinforce the primary
inflammatory response through a mechanism of delayed
secondary damage in the cerebellum, which is suggestive
of the vulnerable nature of the cerebellum as a target of
delayed ischemic and hypoxic insult. Remarkably, cerebral

ischemia and delayed cardiac failure are substantial
causes of mortality and disability around the world [6470]. We, and others, have implicated a pathologic link
between the cerebral ischemia and cardiac cell death
in rodents [7, 11, 65]. Here, we demonstrated that TGI
in NHPs can similarly lead to secondary injury and
harmful modification to cardiac cells. In the heart of
TGI-exposed animals, the apoptotic marker caspase 3
and the inflammatory marker TNF-α were significantly
upregulated compared to the sham heart. Of note, we
observed a significant upregulation of these apoptotic
and inflammatory markers specifically in the ventricles
and throughout the intraventricular septum. Certain

Figure 4: Increased expression of inflammatory markers in the granular cell layer of the cerebellum after TGI. A., C.

Representative photomicrographs of the granular cell layer of the cerebellum. B. Fluorescent intensity examination revealed significant
overexpression of HLA-DR cells in the granular cell layer of the cerebellum of the TGI NHP when compared to sham NHP (p’s < 0.0001).
D. Fluorescent intensity examination revealed significant upregulation of macrophages (CD68+ cells) in the granular cell layer of the
cerebellum of the TGI NHP when compared to sham NHP (p’s < 0.05). Scale bar = 50 µm. Student t-test, p’s < 0.0001. Data are expressed
as mean ± SEM.
www.impactjournals.com/oncotarget
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pathologic conditions can alter the pattern and function
of myocardial contractility [66-79]; however, there is still
much to be uncovered about the mechanism in which
cerebral ischemia affects heart function. Currently, we
recognize that a significant physiological change occurs
via the inability of the ischemic brain to control heart rate,
which is suggestive of an autonomic relationship between
the ischemic brain and compromised heart function [12,
71, 80]. In addition, studies have revealed that insular
cortex damage may disrupt this autonomic balance that
can subsequently lead to potentially fatal arrhythmias and

death [74-81]. Thus, the observed significant increments
in caspase 3 and TNF-α are highly suggestive that an
indirect pathological pathway of cell death exists between
the ischemic brain and the heart in the chronic phase
following TGI.
Although we detected here the presence of
inflammatory markers within the cerebellum and the
heart, these “inflamed cells” likely only correspond to a
small number of inflammatory cells that manifest within
the brain and periphery. However, because cell death is a
dynamic process, even the minimum level of inflammatory

Figure 5: Increased expression of HLA-DR, caspase 3, TNF-α and CD68 in the heart after TGI. Fluorescent intensity

analysis revealed significant upregulation of HLA-DR cells A. and caspase 3 B. in the left ventricle of the TGI NHP heart when compared
to the left ventricle of the sham NHP heart (p’s < 0.05). C. Representative photomicrographs of a left ventricle section of the heart showing
positive expression of HLA-DR (human leukocyte marker) and caspase 3 (upstream regulator of apoptosis) after TGI. Scale bar = 50
µm. Student t-test, p’s < 0.0001. Data are expressed as mean ± SEM. Fluorescent intensity analysis demonstrated significant upregulation
of HLA-DR D. and TNF-α E. in the left ventricle of the TGI NHP heart when compared to the left ventricle of the sham NHP heart (p’s
< 0.05). F. Representative photomicrographs of a left ventricle section of the heart showing positive expression of HLA-DR (human
leukocyte marker) and TNF-α (pro-inflammatory cytokine marker) after TGI. Similarly, fluorescent intensity quantifications demonstrated
significant upregulation of macrophages (CD68+ cells) in the left ventricle of the TGI NHP heart relative to the left ventricle of the sham
NHP heart G. (p’s < 0.05). H. Representative photomicrographs of a left ventricle section of the heart showing positive expression of
CD68+ macrophages post TGI. Scale bar = 50 µm. Student t-test, p’s < 0.0001. Data are expressed as mean ± SEM.
www.impactjournals.com/oncotarget
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response may represent a positive-feedback loop that can
eventually excite the formation of new inflammatory and
immune cells to create a variety of mediators including
pro- cell death cytokines that are able to directly act on
the brain and peripheral organs [82]. The notion that
anesthesia may preclude ischemia-like symptoms in the
brain and the heart has been recognized [83-85], thus
a caveat of the study is that since the present animals
were subjected to prolonged general anesthesia, then it
is possible that some of the pathological symptoms seen
here may be due to anesthesia effects. However, our
study involved a chronic survival (i.e., 6 months postTGI), and the control animals were also subjected to
prolonged anesthesia, which should eliminate many of the
reported anesthesia effects contributing to the observed
pathological outcomes. We believe that further analysis of
immunomodulatory cells of the NHP brain and peripheral
organs will enhance our knowledge about the evolution
of neurodegenerative secondary injuries at delayed time
points in ischemia-plagued neurological diseases.
The current study supports a pathologic link
between ischemia in the CNS and secondary cell injury
in both distal brain regions (cerebellum) and peripheral
organs (heart) which may further contribute to the delayed
functional impairments in survivors of global ischemia.
We previously reported this brain-heart interaction in
experimental stroke model in rodents [7]. In this study, we
were able to extend this pathologic relationship to a larger
animal model by using NHPs. This translational approach
further advances our understanding of the molecular,
cellular, and anatomical modifications that occur following
ischemia, and will likely open new avenues of research
for developing novel therapies that encompass these
overlapping pathological brain and heart manifestations
inherent in cerebrovascular and cardiovascular diseases.

NHPs were housed in cages in a temperature- and
humidity-controlled room that was maintained on 12/12
hour-light/dark cycles. They had free access to food and
water. All necessary steps were performed to minimize
animal pain and stress throughout the study. All the
immunocytochemical and quantification analysis were
performed double blinded. Experimental and control
group information was withheld from the investigators
throughout the study. Eight NHPs (Macaca fuscata) were
either exposed to sham (n = 4) or transient global ischemia
(TGI; n = 4) [5].

MATERIALS AND METHODS

The baseline for physiological parameters (before
clamping the arteries) was as follows: mean arterial blood
pressure, 86 ± 12 (mean SD) mm, Hg: PaO2, 174 ± 29
mm Hg: PaCO2, 32 ± 2 mm Hg: HCO3, 30 ± 6 mm Hg:
SaO2, 99 ± 0.2%: pH, 7.5 ± 0.1: rectal temperature, 37 ±
0.5°C: and blood glucose concentrations, 90 ± 20 mg/dl.
Immediately after clamping the arteries, all NHP displayed
pupil dilation and the mean arterial blood pressure
increased to 170 ± 10 mm Hg. However, immediately
after reperfusion, NHP became normotensive meaning that
all the physiological parameters became normal similar
to baseline levels. Before clamping of the arteries, the
cerebral blood flow was constant at 40 ml/100 g brain/min
and during ischemia (clamping of the arteries) it decreased
to 0-1 ml/100 g brain/min. NHP showed uneventful
recovery within 1-3 h post-ischemic insult.

Stroke surgery
Stroke surgery was performed using the transient
global ischemia (TGI) technique as described in previous
studies [86-88]. NHPs were anesthetized with a mixture
of 1-2% halothane mixed with 40% O2 and 60% N2O
via a face mask, and body temperature was maintained
at 37± 0.3°C during the surgical procedures. Using
thoraco-laparotomy technique, the brachiocephalic and
left subclavian arteries were exposed, and subsequently
clipped for 20 min just distal to the bifurcation from the
aortic arch. For sham NHP surgery, the procedure involved
anesthetizing the animal and exposing and isolating the
right brachiocephalic and left subclavian arteries without
clipping or inserting the filament. Thereafter, incisions
were closed and animals were allowed to recover
from anesthesia. Please see table for neurological and
histological observations in Supplementary Materials.
All animals were euthanized at 6 months post-surgery for
subsequent analysis.

Animal status and physiological parameters

Subjects
Brain and heart tissues used in the present
histological and immunohistochemical studies were
obtained from a separate cohort of animals that belonged
to our original study [5] which underwent the same TGI
procedure, but were allowed to survive up to 6 months
post-surgery. Eight adult (about 8 years of age) Rhesus
(Macaca mulatta), weighing about 4.8 to 6.0 kg were
used on the present study. All experimental procedures
were approved by the Institutional Animal Care and Use
Committee in accordance with the NIH Guide for the
Care and Use of Laboratory Animals (Bethesda, MD,
USA). The animals were housed in an Association for
Assessment and Accreditation of Laboratory Animal
Care International-accredited NHP facility (57-R-0002).
www.impactjournals.com/oncotarget

102828

Oncotarget

Brain and organ harvesting, fixation, and
sectioning

Immunofluorescent staining
Staining for GFAP and TNF-α positive cells was
conducted on every 1/6 sections, 40 µm thick, lateral
sections from the vermis and cerebellar hemispheres.
Cerebellar sections were washed three times for 10
minutes in 0.1M PBS. Six sections were incubated with
saline sodium citrate (SSC) solution at PH 6 for 40
minutes at 80º C for antigen retrieval. Then, samples were
blocked for 60 min at room temperature with 8% normal
goat serum (Invitrogen, CA) in 0.1M PBS containing
0.1% Tween 20 (PBST) (Sigma). Sections were then
incubated overnight at 4°C with rabbit polyclonal antihuman TNF-α (1:200; life technologies, PA1-26810) and
chicken polyclonal anti-human GFAP (1:100; Abcam,
ab4674) with 3% normal goat serum. Then, the sections
were washed five times for ten minutes in 0.1M PBST and
soaked in 5% normal goat serum in 0.1M PBST containing
corresponding secondary antibodies, goat anti-rabbit IgGAlexa 594 (red) (1:1500; Invitrogen), and in goat antichicken IgG-Alexa 488 (green) (1:400; Invitrogen) for
90 minutes. Finally, cerebellar sections were washed five
times for ten minutes in 0.1M PBST and three times for
five minutes in 0.1M PBS, processed for 1:300 Hoechst
33258 (bisBenzimideH 33258 trihydrochloride, Sigma)
for 30 min, washed in 0.1M PBS, and cover-slipped with
Fluoromount (Aqueous Mounting Medium; sigma F4680).
Cerebellar sections were examined using a confocal
microscope (Olympus). Control studies included exclusion
of primary antibody substituted with 5% normal goat
serum in 0.1M PBS. No immunoreactivity was observed
in these controls.
HLA-DR alpha is one of the HLA class II alpha
chain paralogues. It plays a central role in the immune
system by presenting peptides derived from extracellular
proteins. Adaptive immunity is mediated by T cells, and its
effectors CD8+T cells, B cells and activated macrophages
(M1) expressing HLA or MHC II antigen presenting
cells and IFN-γ altogether instigate an inflammatory
response to injury. The present immunostaining focused
on characterizing this Th1/M1 pro-inflammatory response
using HLA-DR+ cells as markers of inflammation.
Staining for inflammation was conducting by targeting
ED1/CD68 and HLA-DRA and TNF-α on every 1/6
of the vermis, cerebellar hemispheres and transverse
sections from the base of the heart to the apex. In all
animals, sections were anatomically matched. Series of
6 to 4 sections per NHP were processed for ED1/CD68
and HLA-DR staining. Four transverse sections of the
base of the heart whereby the ventricles are easily noted
(40 µm) were washed 6 times in 0.1M phosphate-buffered
saline (PBS) to clean the section from the cryoprotectant.
Afterwards, sections were incubated with saline sodium
citrate (SSC) solution at PH 6 for 40 minutes at 80ºC for
antigen retrieval. Later, sections were subjected to 2%
hydrogen peroxide (H2O2) solution for 20 minutes and

Under deep anesthesia, NHPs were re-anaesthetized
and perfused transcardially. Briefly, NHPs were perfused
through the ascending aorta with 500 mL of saline,
followed by 1000 mL of 4% paraformaldehyde in
phosphate buffer (PB). The cerebellum and the hearts
were removed and post-fixed in the same fixative for 24
h, followed by 30% sucrose in PB until completely sunk.
Series of lateral sections were collected throughout the
cerebellum (the vermis and the hemisphere) at a thickness
of 40µm using with a cryostat and then stored at -20°C
in cryoprotectant solution. Series of transverse sections
from the short axis of the base (ventricles) to the apex at
a thickness of 40µm were collected and mounted directly
onto slides and storage at -20°C.

Immunohistochemistry
Cerebellar Purkinje neurons were labeled using anticalbindin antibody. Staining was conducted on every 1/6
lateral section of the vermis and cerebellar hemispheres.
In all NHPs, sections were anatomically matched. Series
of 6 sections per NHP were processed for calbindin
staining. Six free-floating coronal sections (40 µm) were
washed 3 times in 0.1M phosphate-buffered saline (PBS)
to clean the section from the cryoprotectant. Afterwards,
all sections were incubated in 2% hydrogen peroxide
(H2O2) and 40% methanol solution for 20 minutes and
washed 3 times with 0.1M PBS for 10 minutes each wash.
Next, all cerebellar sections were incubated in blocking
solution for 1 hour using 0.1M PBS supplemented with
10% normal goat serum and 0.1% Triton X-100. Sections
were then incubated overnight at 4ºC with rabbit anticalbindin (1:300; Cell signaling, 2173), antibody markers
in 0.1M PBS supplemented with 3% normal serum and
0.1% triton X-100. Sections were then washed 3 times
with 0.1M PBS and incubated in biotinylated goat antirabbit secondary antibody (1:200; Vector Laboratories,
Burlingame, CA) in 0.1M PBS supplemented with normal
goat serum, and 0.1% Triton X-100 for 1 hour. Next, the
sections were incubated for 60 minutes in avidin-biotin
substrate (ABC kit, Vector Laboratories, Burlingame, CA)
and washed 3 times with 0.1M PBS for 10 minute each
wash. All sections were then incubated for 1 minute in
3, 30-diaminobenzidine (DAB) without metal enhancer
(Vector Laboratories) and washed 3 times with 0.1M PBS
for 10 minutes each wash. Sections were then mounted
onto glass slides, dehydrated in ascending ethanol
concentration (70%, 95%, and 100%) for 2 minutes each
and 2 minutes in xylenes, and cover-slipped using toluene
as mounting medium.
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washed 3 times with 0.1M PBS for 10 minutes each wash.
Next, all sections were incubated in blocking solution for
1 hour using 0.1M PBS supplemented with 5% normal
goat serum (Invitrogen, CA) and 0.1% Triton X-100.
Sections were then incubated overnight at 4°C with mouse
anti-human CD68 (1:100 Bio-rad MCA341), HLA-DR
(1:600 Dako M0746), and rabbit polyclonal anti-human
TNF-α (1:200; life technologies, PA1-26810antibody
markers in 0.1M PBS supplemented with 3% normal
serum and 0.1% triton X-100. Sections were then washed
3 times with 0.1M PBS and incubated in in goat antimouse IgG-Alexa 488 (green) (1:400; Invitrogen) and
goat anti-rabbit igG-Alexa 594 (red) (1:1500; Invitrogen)
in 0.1M PBS supplemented with normal goat serum, and
0.1% Triton X-100 for 1 hour and washed 3 times with
0.1M PBS for 10 minute each wash. Finally, sections were
washed five times for ten minutes in PBST and three times
for five minutes in PBS, processed for Hoechst 33258
(bisBenzimideH 33258 trihydrochloride, Sigma) for 30
min, washed in PBS, and cover-slipped with Fluoromount
(Aqueous Mounting Medium; sigma F4680).
Four transverse sections of the base of the heart
whereby the ventricles are easily noted (40 µm) were
washed 6 times in 0.1M phosphate-buffered saline (PBS)
to clean the section from the cryoprotectant. Afterwards,
sections were incubated with saline sodium citrate (SSC)
solution at PH 6 for 40 minutes at 80ºC for antigen
retrieval. Later, sections were subjected to 2% hydrogen
peroxide (H2O2) solution for 20 minutes and washed 3
times with 0.1M PBS for 10 minutes each wash. Next,
all sections were incubated in blocking solution for 1
hour using 0.1M PBS supplemented with 5% normal goat
serum (Invitrogen, CA) and 0.1% Triton X-100. Sections
were then incubated overnight at 4°C with mouse antihuman HLA-DR (human leukocyte antigen; 1:600 Dako
M0746), and rabbit polyclonal anti-human caspase 3
(1:250) antibody markers in 0.1M PBS supplemented with
3% normal serum and 0.1% triton X-100. Sections were
then washed 3 times with 0.1M PBS and incubated in goat
anti-mouse IgG-Alexa 488 (green) (1:400; Invitrogen) and
goat anti-rabbit igG-Alexa 594 (red) (1:1500; Invitrogen)
in 0.1M PBS supplemented with normal goat serum, and
0.1% Triton X-100 for 1 hour and washed 3 times with
0.1M PBS for 10 minute each wash. Finally, sections were
washed five times for ten minutes in PBST and three times
for five minutes in PBS, processed for Hoechst 33258
(bisBenzimideH 33258 trihydrochloride, Sigma) for 30
min, washed in PBS, and cover-slipped with Fluoromount
(Aqueous Mounting Medium; sigma F4680).

were taken from the cerebellum in TGI and sham
cerebellum. Of note, section thicknesses were confirmed
as being between 20.0-21.0 microns after dehydration, and
this did not statistically differ between groups. Calbindin
positive cells were examined using the Cavalieri estimator
probe of the unbiased stereological cell technique 19
revealing the volume of calbindin positive neurons in the
cerebellum. All samplings were optimized to count at least
300 cells per cerebellar hemisphere with error coefficients
less than 0.07. The Cavalieri estimator was executed
using a point grid spaced equally both across and down
directions. A grid space of 100 µm was used in order to
cover the different gray and white matter regions each one
representing our region of interest (ROI) [88].

Analysis of fluorescent staining
From all sections, approximately 4 to 6 images of
20X magnification were taken from each lateral cerebellar
section and from each transverse sections of the heart
using confocal microscopy (Olympus) and analyzed with
ImageJ (National Institutes of Health, Bethesda, MD).
All photomicrographs were converted to gray scale.
Background was selected from blank control images,
and subsequently used to subtract the background from
all images. The same threshold was used for all images.
Thereafter, the staining intensity of each section was
quantified as the average optical density readings of 4
randomly selected areas within that section. The final
staining intensity of each group resulted as the average of
each staining intensity per section.

Statistical analysis
All data were expressed as mean ± SEM and
statistically evaluated using two-way ANOVA followed
by Bonferonni’s test (GraphPad version 5.01). In addition,
Student’s t-tests were also used to determine and compare
the effect of TGI stroke NHP versus sham NHP. We used
the Pearson correlation test to compare the alterations of
volume densities of Purkinje Cells and TUNEL+ staining
intensity. All comparisons were considered significant at
p < 0.05.

Abbreviations
BNP: Brain natriuretic peptide; CRP: C-reactive
protein; GFAP: Glial fibrillary acidic protein; HLA-DR:
Human Leukocyte Antigen - antigen D Related; IgG:
Immunoglobulin G; OGD: Oxygen glucose deprivation;
NPCs: Neural progenitor cells; PBST: Phosphate buffer
saline TX-100; PBS: Phosphate buffer saline; SSC: Saline
sodium citrate; TNF-α: Tumor necrosis factor alpha;
TUNEL: Terminal deoxynucleotidyl transferase dUTP
nick end labeling

Stereological analysis: Cavalieri estimator
Unbiased stereology was performed on cerebellar
sections immunostained with calbindin to estimate
the Purkinje cells volume. Sets of 1/6 section, ~6
systematically random sections, of about 240 µm apart,
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